ascopubs.org

Ki-67 Staining Is a Strong Predictor of Distant Metastasis and Mortality for Men With Prostate Cancer Treated With Radiotherapy Plus Androgen Deprivation: Radiation Therapy ...

Phase II Randomized Study of Vaccine Treatment of Advanced Prostate Cancer (E7897): A Trial of the Eastern Cooperative Oncology Group Ki67-SI was the most significant determinant of DM and CSD and was ...
Medscape

Ki-67 Is a Strong Prognostic Marker of Non-small Cell Lung Cancer When Tissue Heterogeneity Is Considered

Background: Ki-67 expression is a well-established prognostic marker in various cancers. However, Ki-67 expression is also known as being heterogeneous. We investigated the prognostic significance of ...
Medscape

Expression of Histone Deacetylases 1, 2 and 3 in Urothelial Bladder Cancer

HDAC 1–3 protein expression in bladder cancer tissue samples was investigated by immunohistochemical analysis of the TMA containing 174 specimens from patients with a primary urothelial carcinoma of ...
Business Wire

Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its Ki-67 IHC MIB-1 pharmDx (Dako Omnis) is now FDA approved as an aid in identifying patients with early ...
Nasdaq

Agilent Technologies Gets FDA Approval For Ki-67 IHC MIB-1 PharmDx In High-Risk Early Breast Cancer

(RTTNews) - Agilent Technologies Inc. (A) Wednesday said that the U.S. Food and Drug Administration approved its Ki-67 IHC MIB-1 pharmDx (Dako Omnis) as an aid in identifying patients with early ...